Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers

Ovarian cancer (OvCa) is a destructive malignancy due to difficulties in early detection and late advanced-stage diagnoses, leading to high morbidity and mortality rates for women. Currently, the quality treatment for OvCa includes tumor debulking surgery and intravenous platinum-based chemotherapy....

Full description

Bibliographic Details
Main Authors: Melayshia McFadden, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
ovarian cancer
nanoparticles
targeted drug delivery
drug resistance
Online Access:https://www.mdpi.com/2072-6694/13/21/5480

Similar Items

Similar Items